The FDA just approved a new drug for use in ER+/HER2- metastatic breast cancer, based on a large study led by Fred Hutch's Dr ...
Phase 1/2 DELIVER data demonstrated statistically significant dystrophin expression, functional improvements, and a favorable safety profile with z-rostudirsen.
NOT accepting new clients. Hi there! I'm Tara, a Licensed Independent Clinical Social Worker, and owner of North Shore Roots LLC. I've been in the field for 5 years and have worked with clients of all ...
You will feel it when you sit with me, this is my life's calling. I was lucky enough to walk the path of healing from an early age because of a devastating life trauma. This brought me to my deep ...
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to EMD Serono's investigational drug ...
The FDA has approved Leqembi Iqlik (lecanemab-irmb) subcutaneous weekly starting dose, enabling fully at-home treatment ...
Morning Overview on MSN
Regulators cleared Keytruda with chemo before and after surgery for aggressive bladder cancer
Adults diagnosed with muscle-invasive bladder cancer gained a new treatment option on July 10, 2026, when the FDA cleared the combination of pembrolizumab and enfortumab vedotin for use both before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results